| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Hansard Adam is a Chief Commercial Officer at Applied Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $4.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | APLT Applied Therapeutics, Inc. | Chief Commercial Officer | Sell | 48,871 | $5.39 | $263,414.69 | -6.3% | -9.5% | -91.2% | |
| Nov 30, 2023 | APLT Applied Therapeutics, Inc. | Chief Commercial Officer | Sell | 965 | $1.97 | $1,901.05 | -0.3% | +250.7% | -3.8% | |
| Sep 27, 2023 | APLT Applied Therapeutics, Inc. | Chief Commercial Officer | Sell | 9,720 | $2.70 | $26,244.00 | -2.5% | +14.4% | +218.6% | |
| Jan 11, 2023 | APLT Applied Therapeutics, Inc. | Chief Commercial Officer | Sell | 4,495 | $0.91 | $4,090.45 | -4.6% | -22.2% | +147.5% | |
| May 26, 2021 | APLT Applied Therapeutics, Inc. | Chief Commercial Officer | Sell | 2,894 | $18.35 | $53,104.90 | -7.9% | -13.1% | -92.9% |